Basit öğe kaydını göster

dc.contributor.authorSerdengecti, S
dc.contributor.authorBerkarda, B
dc.contributor.authorBuyukunal, Evin
dc.contributor.authorDemirelli, FUAT HULUSİ
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorDoventas, Alper
dc.contributor.authorMandel, Nil Kler
dc.contributor.authorDemir, G
dc.contributor.authorTurna, H
dc.date.accessioned2021-03-03T08:54:18Z
dc.date.available2021-03-03T08:54:18Z
dc.date.issued1999
dc.identifier.citationOzguroglu M., Turna H., Demir G., Doventas A., Demirelli F. H. , Mandel N. K. , Buyukunal E., Serdengecti S., Berkarda B., "Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.22, sa.6, ss.615-618, 1999
dc.identifier.issn0277-3732
dc.identifier.othervv_1032021
dc.identifier.otherav_1a21a30e-2fe2-40f7-942f-6e87c90c71dd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/22835
dc.identifier.urihttps://doi.org/10.1097/00000421-199912000-00014
dc.description.abstractCA-125: a commonly used tumor marker for epithelial ovarian cancer, Is a glycoprotein found in normal tissues derived from coelomic epithelia. Increased serum levels of CA-125 have also been found in nongynecologic tumors and nonmalignant diseases involving the peritoneum. A few recent studies and sporadic case reports have reported increased CA-125 levels in patients with non-Hodgkin's lymphoma (NHL). In our study, we aimed to evaluate the serum levels of CA-125 in patients with NHL and determine its potential role to show disease activity in NHL. Serum levels of CA-125 were measured in 61 patients with NHL and were found to be correlated with clinical stage, site of involvement, and disease activity.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titleUsefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume22
dc.identifier.issue6
dc.identifier.startpage615
dc.identifier.endpage618
dc.contributor.firstauthorID14634


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster